Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

Authors :: Al-Sawaf O
Zhang C
Jin HY
Robrecht S
Choi Y
Balasubramanian S
Kotak A
Chang YM
Fink AM
Tausch E
Schneider C
Ritgen M
Kreuzer KA
Chyla B
Paulson JN
Pallasch CP
Frenzel LP
Peifer M
Eichhorst B
Stilgenbauer S
Jiang Y
Hallek M
Fischer K
Source :: Nature communications [Nat Commun] 2023 Oct 23; Vol. 14 (1), pp. 6724. Date of Electronic Publication: 2023 Oct 23.
Publication Year :: 2023

Full Text Access

Tools